Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

FDA Approves the First Drug for Obese Dogs

Filed in archive Drugs, Vaccines and Therapeutics by ruth on February 20, 2007

FDA Approves the First Drug for Obese Dogs
The US FDA has approved Slentrol (dirlotapide), a prescription drug for the management of obesity in dogs. Slentrol reduces appetite and fat absorption to produce weight loss.
Slentrol is a new chemical entity, called a selective microsomal triglyceride transfer protein inhibitor, which blocks the assembly and release of lipoproteins into the bloodstream. The mechanism for producing weight loss is not completely understood, but seems to result from reduced fat absorption and a satiety signal from lipid-filled cells lining the intestine.

Slentrol is aimed for dogs weighing 20 percent more than their ideal weightlinks. For more info,






Permalink: FDA Approves the First Drug for Obese Dogs
Tags: obesity  dogs  pets  slentrol  biotech  approves+first  drug+obese  obese+dogs 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/54356





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells